AI assistant
Sending…
Ascletis Pharma Inc. — Earnings Release 2004
Apr 12, 2005
50081_rns_2005-04-12_45cfba63-5e39-467b-9105-40ee7546119e.htm
Earnings Release
Open in viewerOpens in your device viewer
Listed Company Information
| Listed Company Information |
| WORLD HOUSEWARE<00713> - Results Announcement World Houseware (Holdings) Limited announced on 12/04/2005: (stock code: 00713 ) Year end date: 31/12/2004 Currency: HKD Auditors' Report: Unqualified (Audited ) (Audited ) Last Current Corresponding Period Period from 01/01/2004 from 01/01/2003 to 31/12/2004 to 31/12/2003 Note ('000 ) ('000 ) Turnover : 870,936 737,541 Profit/(Loss) from Operations : 28,129 43,445 Finance cost : (5,372) (3,485) Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : N/A N/A Profit/(Loss) after Tax & MI : 19,858 37,028 % Change over Last Period : -46.4 % EPS/(LPS)-Basic (in dollars) : 0.029 0.055 -Diluted (in dollars) : N/A 0.055 Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : 19,858 37,028 Final Dividend : 0.5 cent 0.5 cent per Share (Specify if with other : N/A N/A options) B/C Dates for Final Dividend : 19/05/2005 to 25/05/2005 bdi. Payable Date : 27/06/2005 B/C Dates for Annual General Meeting : 19/05/2005 to 25/05/2005 bdi. Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remarks: 1: EARNINGS PER SHARE The calculations of the basic and diluted earnings per share are as follows: 2004 2003 HK$'000 HK$'000 Earnings for the purpose of calculating basic and diluted earnings per share 19,858 37,028 ======== ======== Number of shares 2004 2003 Number of shares for the purpose of calculating basic earnings per share 676,417,401 676,417,401 ============ Effect of dilutive potential shares: Share options 152,954 ------------ Weighted average number of shares for the purpose of calculating diluted earnings per share 676,570,355 ============ Basic earnings per share 2.9 cents 5.5 cents ========== ========== Diluted earnings per share N/A 5.5 cents ========== ========== In 2004, no diluted earnings per share has been presented because the exercise price of the Company's options was higher than the average market price of the Company's shares. |
More from Ascletis Pharma Inc.
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 29
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 7
Earnings Release
2026
Mar 31
Report Publication Announcement
2026
Mar 18
Regulatory Filings
2026
Mar 17